Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Clinical Endocrinology|May 1, 1993
Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 casesS Casanova, M Rosenberg-Bourgin, D Farkas, et al.
The Journal of Clinical Endocrinology and Metabolism|November 17, 2009
Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemiaL Tessonnier, F Sebag, C Ghander, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1982
[Determination of plasma catecholamine. Effects of glucagon administration]B Conte-Devolx, C Oliver, M Orlando, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study GroupP Niccoli, N Wion-Barbot, P Caron, et al.
European Journal of Endocrinology|February 15, 2001
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective studyL Nguyen, P Niccoli-Sire, P Caron, et al.
Annales D'Endocrinologie|April 6, 1999
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]S Richard, S Giraud, C Beroud, et al.
European Journal of Endocrinology|November 27, 1999
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)P Niccoli-Sire, A Murat, E Baudin, et al.
Neuropeptides|March 9, 2002
Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonistR Cirillo, M Astolfi, B Conte, et al.
Clinical Endocrinology|May 14, 1998
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonineE Modigliani, R Cohen, J M Campos, et al.
Annales De Chirurgie|September 30, 1998
[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer]A Murat, E Modigliani, B Conte-Devolx, et al.
Pageof 21